I'd like to see this problem of inequitable credit and technology sharing solved.
If updated vaccines/therapeutics/diagnostics are developed, these should be sent first to places that reported the new variant(s) used in the update.
There should be a new credit sharing system.
If updated vaccines/therapeutics/diagnostics are developed, these should be sent first to places that reported the new variant(s) used in the update.
There should be a new credit sharing system.
https://twitter.com/Tuliodna/status/1467710032821338112
In a pandemic when novel SARS-CoV-2 sequences can rapidly translate into updated vaccines, diagnostics & therapeutics, why don't prominent journals guarantee a "Resource" paper for the researchers who are the first to share the sequence of a new variant of interest/concern?
This way, data sharing is highly incentivized and accelerated.
Both the sequence contributors and the journal are rewarded due to hundreds or thousands of citations of the Resource paper.
Both the sequence contributors and the journal are rewarded due to hundreds or thousands of citations of the Resource paper.
It costs top journals next to nothing to guarantee a short Resource or Analysis or Dataset paper to anyone who shares the next variant of interest or concern first.
It also gives researchers a guilt-free way to credit our colleagues who have immediately shared life-saving data.
It also gives researchers a guilt-free way to credit our colleagues who have immediately shared life-saving data.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
